益方生物 (688382.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(益方生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年第三季度2025年第二季度2025年第一季度2024年第四季度2024年第三季度2024年第二季度2024年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 会员可见会员可见会员可见会员可见4,283,084.626,267,169.528,606,045.10
 营业收入(元) 会员可见会员可见会员可见会员可见4,283,084.626,267,169.528,606,045.10
二、营业总成本(元) 会员可见会员可见会员可见会员可见102,632,668.24133,651,596.7391,335,787.52
 营业成本(元) 会员可见会员可见会员可见会员可见713,775.752,272,660.504,044,612.85
 研发费用(元) 会员可见会员可见会员可见会员可见86,765,416.51124,158,473.0184,752,226.60
 营业税金及附加(元) 会员可见会员可见会员可见会员可见9,778.9531,788.0729,340.62
 管理费用(元) 会员可见会员可见会员可见会员可见18,887,517.2313,652,585.7010,644,755.92
 财务费用(元) 会员可见会员可见会员可见会员可见-3,743,820.20-6,463,910.55-8,135,148.47
  其中:利息费用(元) --会员可见----
  其中:利息收入(元) 会员可见会员可见会员可见会员可见-5,512,827.40-6,141,132.74-8,058,138.58
 信用减值损失(元) 会员可见会员可见会员可见会员可见-208,581.06-4,092,892.11-447,924.66
三、其他经营收益
 加:公允价值变动收益(元) 会员可见会员可见会员可见会员可见570,000.00--
 加:投资收益(元) 会员可见------
 其他收益(元) -会员可见会员可见会员可见6,900,000.00--
四、营业利润(元) 会员可见会员可见会员可见会员可见-91,088,164.68-131,040,677.96-83,177,667.08
五、利润总额(元) 会员可见会员可见会员可见会员可见-91,088,164.68-131,040,677.96-83,177,667.08
六、净利润(元) 会员可见会员可见会员可见会员可见-91,088,164.68-131,040,677.96-83,177,667.08
(一)按经营持续性分类
  持续经营净利润(元) 会员可见会员可见会员可见会员可见-91,088,164.68-131,040,677.96-83,177,667.08
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 会员可见会员可见会员可见会员可见-91,088,164.68-131,040,677.96-83,177,667.08
 扣除非经常性损益后的净利润(元) 会员可见会员可见会员可见会员可见-98,558,164.68-131,477,319.32-83,177,667.08
七、每股收益
 一、基本每股收益(元) 会员可见会员可见会员可见会员可见-0.16-0.23-0.14
 二、稀释每股收益(元) 会员可见会员可见会员可见会员可见-0.16-0.23-0.14
八、其他综合收益(元) 会员可见会员可见会员可见会员可见-645,334.93-390,983.80-593,516.15
 归属于母公司股东的其他综合收益(元) 会员可见会员可见会员可见会员可见-645,334.93-390,983.80-593,516.15
九、综合收益总额(元) 会员可见会员可见会员可见会员可见-91,733,499.61-131,431,661.76-83,771,183.23
 归属于母公司所有者的综合收益总额(元) 会员可见会员可见会员可见会员可见-91,733,499.61-131,431,661.76-83,771,183.23
公告日期 2025-10-30 00:00:002025-08-23 00:00:002025-04-29 00:00:002025-04-26 00:00:002024-10-30 00:00:002024-08-23 00:00:002024-04-30 00:00:00
审计意见(境内) 标准无保留意见

前瞻产业研究院